Top 100 Health Diagnostics Startups to Watch in 2026
The health diagnostics sector is seeing major growth, driven by advances in artificial intelligence and biotechnology. Companies are developing new ways to monitor health and detect diseases earlier.
This includes startups like Freenome, which has raised $1.5 billion for its cancer detection blood tests. Others, like the recently founded Doctronic, are using AI to provide instant medical guidance.
Below is our list of 100 Health Diagnostics startups worth keeping an eye on.
Failory's Top 10 Picks
Doctronic builds an AI-driven platform that delivers instant and secure medical guidance. The service provides seamless 24/7 access to licensed physicians for further consultation and care.
| Headquarters | New York, New York, United States |
| Year Founded | 2024 |
| Founders | Adam Oskowitz, Matt Pavelle |
| Funding Amount | $25M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Series A |
| Top Investors | Lightspeed Venture Partners, Union Square Ventures, MANTIS Venture Capital, Tusk Venture Partners, Seven Stars |
Hormona created a health platform that uses AI and at-home testing to help women track and manage their hormonal health. Their app provides personalized insights and guidance to help users understand their body's unique hormonal patterns.
| Headquarters | London, England, United Kingdom |
| Year Founded | 2020 |
| Founders | Jasmine Tagesson, Karolina Löfqvist |
| Funding Amount | £6.6M |
| Startup Size | Founding Team (1-10) |
| Last Funding Status | Grant |
| Top Investors | Techstars, Voima Ventures, SFC Capital, Supernode Global, Innovate UK |
Character Biosciences built a platform that integrates genomics, clinical data, and AI to create a deeper understanding of human diseases. They use this technology to discover and develop novel therapeutics, starting with treatments for age-related macular degeneration.
| Headquarters | Jersey City, New Jersey, United States |
| Year Founded | 2018 |
| Founders | Cheng Zhang, Marcel van der Brug |
| Funding Amount | $137M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Series B |
| Top Investors | Catalio Capital Management, Industry Ventures, S32, Cantos, Casdin Capital |
Element Biosciences creates advanced genetic analysis tools for the life sciences industry. Their AVITI System provides researchers with a powerful and cost-effective benchtop platform for DNA sequencing.
| Headquarters | San Diego, California, United States |
| Year Founded | 2017 |
| Founders | Matt Kellinger, Michael Previte, Molly He |
| Funding Amount | $678M |
| Startup Size | Large Team (251-1,000) |
| Last Funding Status | Series D |
| Top Investors | Wellington Management, RA Capital Management, Samsung Electronics, Venrock, Fidelity |
Function Health has built a health platform that provides members with access to over 100 lab tests for a complete look inside their bodies. The service delivers ongoing health insights, helping people shift from reactive treatment to proactive health management.
| Headquarters | Austin, Texas, United States |
| Year Founded | 2022 |
| Founders | Daniel Swerdlin, Jonathan Swerdlin, Mark Hyman, Mike Nemke, Pranitha Patil, Seth Weisfeld |
| Funding Amount | $56M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Series B |
| Top Investors | Andreessen Horowitz, Bossa Invest, QuantumLight, 53 Stations, SignalRank |
Pearl creates AI-powered software to advance the quality of dental care for clinics and their patients. The company's core technology provides real-time disease detection in x-rays and offers insights to improve a practice's overall performance.
| Headquarters | West Hollywood, California, United States |
| Year Founded | 2019 |
| Founders | Cambron Carter, Kyle Stanley, Ophir Tanz |
| Funding Amount | $69M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Series B |
| Top Investors | Craft Ventures, Bossa Invest, Irving Investors, Left Lane Capital, Alpha Partners |
Fountain Life has developed a preventative health platform that uses AI-powered screenings to detect potential illnesses early. Based on these diagnostics, they create personalized wellness programs for members focused on longevity and peak performance.
| Headquarters | Naples, Florida, United States |
| Year Founded | 2020 |
| Founders | Peter Diamandis, Robert Hariri, Tony Robbins |
| Funding Amount | $115.1M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Series B |
| Top Investors | Eos Venture Partners, Tony Robbins, Peter Diamandis, Todd R. Wanek, Newcross Healthcare |
Notable created an AI platform that automates administrative and clinical workflows for healthcare organizations. This intelligent automation platform handles everything from patient intake to billing, freeing up staff to concentrate on patient care.
| Headquarters | San Mateo, California, United States |
| Year Founded | 2017 |
| Founders | Adam Ting, Justin White, Pranay Kapadia |
| Funding Amount | $119.2M |
| Startup Size | Large Team (251-1,000) |
| Last Funding Status | Series B |
| Top Investors | Oak HC/FT, 8VC, ICONIQ Growth, Maverick Ventures, Greylock |
meQuilibrium offers a digital platform that provides stress management and resilience-building solutions for employees. Their software uses data analytics and behavioral science to deliver personalized programs aimed at improving workforce well-being.
| Headquarters | Boston, Massachusetts, United States |
| Year Founded | 2010 |
| Founders | Adam Perlman, Jan Bruce |
| Funding Amount | $33.5M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Venture Round |
| Top Investors | Vistara Growth, SAP.iO, Eastward Capital Partners, HLM Venture Partners, Safeguard Scientifics |
Freenome creates blood tests that can detect cancer in its earliest stages. The biotechnology company's multiomics platform is designed to make routine screening more accessible by analyzing a simple blood draw for cancer signals.
| Headquarters | San Francisco, California, United States |
| Year Founded | 2014 |
| Founders | Charles Roberts, Gabriel Otte, Michael Otte, Riley Ennis |
| Funding Amount | $1.5B |
| Startup Size | Large Team (251-1,000) |
| Last Funding Status | Corporate Round |
| Top Investors | Andreessen Horowitz, RA Capital Management, Founders Fund, Cormorant Asset Management, Novartis |
90 Additional Health Diagnostics Startups Worth Following
Our top 10 picks are just a small slice of the exciting work happening in health diagnostics. Many of the most promising new companies are using AI and biotechnology to find new ways of understanding our health.
Together, these startups have raised billions of dollars, with some just starting out and others scaling quickly. Here is a look at the other 90 companies that are reshaping the future of health.
| Startup | Main Industry | Year Founded | Amount Raised | Last Funding Round |
|---|---|---|---|---|
 Superpower | Healthcare | 2022 | $34M | Series A |
 BillionToOne | Biotech | 2016 | $425.9M | Series D |
 Subtle Medical | AI | 2017 | $59.2M | Venture Round |
 Sunrise | Healthcare | 2015 | $49.5M | Venture Round |
 Overjet | AI | 2018 | $130.6M | Series C |
 Predicta Biosciences | Biotech | 2023 | $28.6M | Series A |
 Opus Genetics | Biotech | 2004 | $22.7M | Grant |
 Eyebot | AI | 2021 | $29.9M | Series A |
 Scipher Medicine | Healthcare | 2014 | $227M | Series D |
 Altos Labs | Biotech | 2021 | $3B | Series A |
 Qure AI | AI | 2016 | $125.3M | Series D |
 Human Longevity | Biotech | 2013 | $369.8M | Series B |
 Teal Health | Healthcare | 2020 | $21.5M | Seed |
 Centivax | Biotech | 2020 | $59.2M | Series A |
 Parallel Health | Fashion | 2021 | $2M | Grant |
 Navina | AI | 2018 | $99M | Series C |
 Ultromics | AI | 2017 | $113.8M | Series C |
 Linus Health | Healthcare | 2019 | $64.9M | Series B |
 Ash | Healthcare | 2019 | $16.6M | Series A |
 C2N Diagnostics | Biotech | 2007 | $85.7M | Corporate Round |
 MDisrupt | Healthcare | 2019 | $10M | Venture Round |
 Geneoscopy | Biotech | 2015 | $217.9M | Series C |
 Pictor | Biotech | 2006 | $16.3M | Convertible Note |
 Solv | Marketing | 2016 | $95.1M | Venture Round |
 Parsley Health | Healthcare | 2016 | $36.1M | Venture Round |
 Deciphex | AI | 2017 | $84.9M | Debt Financing |
 Heartbeat Health | Healthcare | 2017 | $53.5M | Series C |
 United Imaging Healthcare | Healthcare | 2011 | CN¥3.3B | Series A |
 Kintsugi | AI | 2019 | $30.9M | Series A |
 Nusano | Biotech | 2013 | $115M | Series C |
 Inflammatix | Biotech | 2016 | $194.8M | Series E |
 Polaris Genomics | Biotech | 2017 | $5.6M | Debt Financing |
 Caristo Diagnostics | Biotech | 2018 | $30.1M | Venture Round |
 Octave | Biotech | 2014 | $142.1M | Series C |
 Samay | AI | 2018 | $5.2M | Grant |
 Corus Orthodontists | Healthcare | 2019 | $203M | Debt Financing |
 Paige | Biotech | 2018 | $220M | Series C |
 illumicell AI | AI | 2023 | $2.3M | Pre-Seed |
 Kipu Health | Healthcare | 2012 | $19.5M | Private Equity |
 Clear Labs | AI | 2014 | $156.5M | Series D |
 CytoVale | AI | 2013 | $228.6M | Venture Round |
 Ainnova Tech | AI | 2021 | $5.8M | Series A |
 Bunkerhill Health | AI | 2022 | $30M | Series A |
 Haystack Oncology | Biotech | 2021 | $56M | Series A |
 Welltory | Media | 2016 | $12.3M | Debt Financing |
 Somatus | Healthcare | 2016 | $465.1M | Series E |
 Scopio Labs | AI | 2015 | $125.1M | Series D |
 Visby Medical | Healthcare | 2012 | $435.8M | Venture Round |
 Nutromics | Biotech | 2017 | $33.5M | Undisclosed |
 CND Life Sciences | Biotech | 2017 | $43.6M | Series A |
 Skin Analytics | Analytics | 2012 | $31M | Series B |
 Melt Pharmaceuticals | Healthcare | 2019 | $77.3M | Series B |
 Ilara Health | Healthcare | 2019 | $10.8M | Debt Financing |
 Hilo | AI | 2018 | $101.7M | Series B |
 Quibim | AI | 2012 | $69.6M | Series A |
 Numab | Biotech | 2011 | CHF172M | Series C |
 MedGenome | Biotech | 2013 | $233M | Series E |
 Yazen | Healthcare | 2021 | $25.6M | Series A |
 Nuclidium | Healthcare | 2018 | CHF84M | Series B |
 Rapidemic | Biotech | 2020 | $3.4M | Grant |
 Therapixel | AI | 2013 | $26.1M | Series B |
 Neuberg Diagnostics | Healthcare | — | ₹9.4B | Private Equity |
 Gene Solutions | Biotech | 2017 | $36M | Venture Round |
 Chipiron | Healthcare | 2020 | $25.8M | Series A |
 FluidAI Medical | AI | 2014 | $35.4M | Grant |
 Practo | Healthcare | 2008 | $228.2M | Series D |
 EndoGene.Bio | Analytics | 2022 | $2.9M | Pre-Seed |
 Aignostics | AI | 2018 | $54.8M | Series B |
 Numan | Enterprise | 2018 | $130.7M | Series B |
 Molbio Diagnostics | Biotech | 2000 | $117.5M | Venture Round |
 Rofim | Healthcare | 2018 | $15M | Venture Round |
 NephroPlus | Healthcare | 2009 | $215.5M | Secondary Market |
 Dxcover | Biotech | 2016 | $24.4M | Venture Round |
 Gradientech | Biotech | 2009 | $11M | Corporate Round |
 Floy | AI | 2021 | €12.4M | Seed |
 Even | Healthcare | 2020 | $70.9M | Series A |
 Redcliffe Labs | Healthcare | 2018 | $151.9M | Series C |
 Connect and Heal | Healthcare | 2015 | $17M | Venture Round |
 Albert Health | AI | 2018 | $2.9M | Venture Round |
 Marvin Behavioral Health | Healthcare | 2020 | $6.2M | Seed |
 United Imaging Intelligence | Healthcare | 2017 | CN¥1B | Series A |
 Orange Health Labs | Healthcare | 2020 | $46.9M | Venture Round |
 Navinci Diagnostics | Biotech | 2004 | SEK90M | Series A |
 Variantyx | Biotech | 2014 | $136.5M | Series D |
 Fortis Healthcare | Biotech | 1996 | ₹1.5B | Debt Financing |
 DEBx Medical | Healthcare | 2019 | €10M | Private Equity |
 aetherAI | AI | 2015 | $36.8M | Venture Round |
 Olakino | AI | 2022 | €529.7k | Convertible Note |
 Retinai | AI | 2016 | CHF15.1M | Series B |
 C Ray Therapeutics | Healthcare | 2020 | $100M | Series A |
